权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Ataxia Investigators Meeting 2016: From Basic Science to Clinical Therapeutics

2016 年共济失调研究者会议：从基础科学到临床治疗

基本信息

批准号：
9051026
负责人：
DAVID ROBINSON LYNCH
金额：
$ 3.5万
依托单位：
CHILDREN'S HOSP OF PHILADELPHIA
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-30 至 2016-09-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9051026
关键词：
Address Affect Ataxia Basic Science Biological Cerebellar degeneration Clinical Clinical Trials Collaborations Communication Country Deglutition Disease Economics Elements Ensure Etiology Europe Eye Movements Family Florida Foundations Funding Future Gait Genetic Genomics Goals Human Industry International Location Movement Multi-Institutional Clinical Trial Nature Patients Phase Postdoctoral Fellow Prevalence Recruitment Activity Research Research Personnel Route Scientific Advances and Accomplishments Scientist Speech Therapeutic Therapeutic Human Experimentation Time Translational Research United States United States National Institutes of Health abstracting base dexterity genetic approach graduate student lectures meetings motor control nervous system disorder novel therapeutic intervention posters programs public health relevance success symposium therapeutic target translational approach

项目摘要

DESCRIPTION (provided by applicant): Ataxia, a disabling and frequently fatal neurological disorder, results from a wide variety of genetic and acquired etiologies. The 6th Ataxia Investigators' Meeting, "AIM 2016: From Basic Science to Clinical Therapeutics" will assemble an international roster of investigators to address the diverse causes of ataxia, to define better the pathogenic basis of ataxia, and to explore routes to therapy. The conference will focus on the most recent scientific advances and emerging integrative approaches toward therapy, with the following objectives: 1) Identify common disease mechanisms, 2) Explore therapeutic strategies, 3) Help establish the future leaders of ataxia research, and 4) Bring trainees (graduate students and postdocs) into contact with ataxia patients and families. AIM 2016 will represent a critical mechanism to facilitate collaboration and discussion on ataxia research and therapeutic approaches, which is of particularly great importance now that the field is entering the phase of meaningful, multi-center clinical trials both in the United States and Europe. The AIM 2016 meeting, affiliated and overlapping with the annual meeting of the largest ataxia foundation in the country occurring at the same hotel, will maximize the impact of this meeting for scientists and patients alike.

描述（由申请人提供）：共济失调是一种致残和经常致命的神经系统疾病，由多种遗传和后天病因引起。第六届共济失调研究者会议，“AIM 2016：从基础科学到临床治疗”将汇集一个国际研究者名册，以解决共济失调的各种原因，更好地定义共济失调的致病基础，并探索治疗途径。会议将重点关注最新的科学进展和新兴的综合治疗方法，目标如下：1）确定常见的疾病机制，2）探索治疗策略，3）帮助建立共济失调研究的未来领导者，以及4）使学员（研究生和博士后）与共济失调患者和家庭接触。AIM 2016将是促进共济失调研究和治疗方法合作和讨论的关键机制，这一点尤其重要，因为该领域正在美国和欧洲进入有意义的多中心临床试验阶段。AIM 2016会议与该国最大的共济失调基金会年会在同一家酒店举行，并与之重叠，将最大限度地发挥这次会议对科学家和患者的影响。